Prana Thoracic was founded with a vision to transform lung cancer intervention through precision surgical solutions. We aim to right-size interventions for those patients seeking earlier options in the management of their disease. Our flagship product, the Prana System, has been meticulously designed to enable image-guided, minimally invasive surgery, conserving healthy tissue and driving personalized treatment plans in a range of conditions including lung cancer.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 08/12/24 | $3,000,000 | Series A Extension |
Cancer Prevention & Research Institute of Texas cultivate(MD) Capital Funds GenHenn Capital Houston Angel Network Texas Medical Center Venture Fund | undisclosed |
